Browsing by Author "Tsou, Ping-Hsien"

Now showing 1 - 4 of 4

Hand-powered centrifugal microfluidic disc with magnetic chitosan bead-based ELISA for antibody quantitation
(2020-08-01)
Lin, Chia-Tung
;
Kuo, Shao-Hsuan
;
Lin, Pei-Heng
;
Chiang, Pei-Huan
;
Lin, Wan-Hsuan
Extreme point-of-care testing (POCT) is a medical test performed at or near patients at a resource-limited condition. POCT technology has advantages over traditional medical lab tests for molecular detection and infection diagnosis, such as being simple, portable, low-cost, and user-friendly. However, some POCT devices might rely on bulky equipment, and some might be easily influenced by components in biofluid, which might result in higher prices and lower accuracy. In this paper, we demonstrated a low-cost method for detecting bacterial infection in the early stage. We designed a hand-powered centrifugal microfluidic (CMF) disc with magnetic chitosan beads (MCBs) to detect specific circulating antibodies in human whole blood. Nine identical units was used for calibration curve plotting and sample testing. The MCBs, generated with another microfluidic chip and coated with MBL proteins (biomarker of drug-resistant Streptococcus pneumoniae, DRSP, taken as an example for bacterial infection), were served as the substrate of sandwich-structured enzyme-linked immunosorbent assays (ELISA) and as the micro stirring sphere at the same time. The limit of detection (LOD) in PBS and human whole blood were 22.67 ng/mL and 24.83 ng/mL, respectively. The comparison between calibration curves from the antibody spiked in human whole blood and that in PBS was shown to prove the high compatibility and low interference of biofluid, and the recovery rate was 92 %. In conclusion, since our low-cost, time-saving, and user-friendly hand-powered CMF device with minimally consumed electricity detected the target antibody precisely, we believe that other similar assays would be feasible as well. Therefore, we are firmly convinced that this alternative POCT device may lead to the development of next-generation healthcare diagnoses.
Quantiferon TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents
(2015-10-01)
Tsou, Ping-Hsien
;
Huang, Wei-Chang
;
Huang, Chen-Cheng
;
Lin, Chen-Fu
;
Wu, Kun-Ming
AimThe study was carried out on elderly nursing home residents in Taiwan. We assessed whether the serial QuantiFERON-TB Gold (QFT-G) assay and serial tuberculin skin test (TST) were reliable tools to predict or exclude the development of active tuberculosis (TB). MethodsThis prospective observational cohort study involved non-bacillus Calmette-Guerin-vaccinated 259 elderly nursing home residents free of active TB at baseline. Of these, 147 were eligible for follow up. Participants underwent serial QFT-G and TST at baseline and 2-year follow up, and were monitored for active TB over 5years. Agreement between QFT-G and TST, incidence rate ratio, positive predictive value, and negative predictive value for progression to active TB were measured. ResultsDuring 5-year follow up, three participants developed active TB. The agreement between these two tests was 54.13% (?=0.167, P=0.001). The incidence rate ratio was 15.8 (P=0.016) for the QFT-G-conversion group compared with the TST-positive group at baseline. Positive predictive value for QFT-G conversion groups was 25%. Negative predictive value was 100% for the TST-negative group at baseline. ConclusionIn the elderly nursing home residents, QFT-G conversion is a more reliable tool to predict the development of active TB. Meanwhile, TST is a valuable tool for predicting the chance of not developing active TB. Geriatr Gerontol Int 2015; 15: 1179-1184.
Rapid and Safe Isolation of Human Peripheral Blood B and T Lymphocytes through Spiral Microfluidic Channels
(2019-05-31)
Chiu, Po-Lin
;
Chang, Chun-Hao
;
Lin, Yu-Ling
;
Tsou, Ping-Hsien
;
Li, Bor-Ran
Peripheral blood lymphocytes (PBLs) are mature lymphocytes that circulate in the blood rather than being localized to organs. A reliable label-free collection approach that can viably and appropriately isolate PBLs to establish in vitro culture systems is crucial for basic research and clinical requirements. However, isolation of PBLs from whole blood is difficult, and so the development of a rapid and safe method to perform this task is required. Microfluidic technology offers opportunities that challenge the performance of macroscale methods. In this study, we proposed a simple spiral microfluidic chip for efficient and high-throughput isolation of lymphocytes from a sample with prelysed RBCs. This spiral microfluidic platform does not rely on antibodies or biological markers for labeling cells of interest while isolating lymphocytes but rather enriches B and T lymphocytes through the different physical properties that are intrinsic to lymphocytes and other blood cells. The device was used to achieve high-throughput (similar to 1.3 x 10(5) cells/min) separation of lymphocytes with high viability (>95%). Compared with previous approaches, our device provided rapid, label-free, high-throughput, and safe lymphocyte separation.
Thermopneumatic suction integrated microfluidic blood analysis system
(2019-03-07)
Yang, Chiao-Hsun
;
Hsieh, Yu-Ling
;
Tsou, Ping-Hsien
;
Li, Bor-Ran
;
交大名義發表
Blood tests provide crucial diagnostic information regarding several diseases. A key factor that affects the precision and accuracy of blood tests is the interference of red blood cells; however, the conventional methods of blood separation are often complicated and time consuming. In this study, we devised a simple but high-efficiency blood separation system on a self-strained microfluidic device that separates 99.7 +/- 0.3% of the plasma in only 6 min. Parameters, such as flow rate, design of the filter trench, and the relative positions of the filter trench and channel, were optimized through microscopic monitoring. Moreover, this air difference-driven device uses a cost-effective and easy-to-use heater device that creates a low-pressure environment in the microchannel within minutes. With the aforementioned advantages, this blood separation device could be another platform choice for point-of-care testing.